Back to search

United States· US:49884-786_9ce53e8f-235a-4ebc-b1b1-4e764daacab2

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

A medicinal product containing olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide, registered in United States by Par Health USA, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedolmesartan medoxomil / amlodipine bes…ATC—REGISTER NO.US:49884-786_9ce53e8f…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Manufacturer
Par Health USA, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    49884-786-09
  • ndc11
    49884-786-11
  • ndc11
    4988478609
    90 TABLET, FILM COATED in 1 BOTTLE (49884-786-09)
  • ndc11
    4988478611
    30 TABLET, FILM COATED in 1 BOTTLE (49884-786-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Amelior Plus Hct
  • Belgium · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
  • Bulgaria · Олмезид Трио, Олместа А Плюс
  • Cyprus · Olmedipin Plus, Orizal Plus
  • Czechia · Sintonyn Combi
  • Germany · Olmeamlo Hct, Olmeamlodipinhct Puren
  • Estonia · Gaduar, Olmesartan Medoxomil/Amlodipine/Hct Accord
  • Spain · Albis Plus, Balzak Plus
  • United Kingdom (Northern Ireland) · Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm, Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm Limited
  • Greece · Comprelan Plus, Gaduar
  • Croatia · Omelia
  • Hungary · Duactan Hct
  • Ireland · Konverge Plus, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
  • Italy · Gaduar, Olmesartan, Amlodipina E Idroclorotiazide Eg
  • Lithuania · Gaduar, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
  • Luxembourg · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
  • Latvia · Gaduar, Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide Accord
  • Malta · Konverge Plus
  • Netherlands · Belfor Hct, Capenon Hct
  • Poland · Amolisa Hct, Elestar Hct
  • Portugal · Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Alter, Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Generis
  • Romania · Inovum Hct, Sevikar Hct
  • Slovenia · Olectan Hct, Olsitri
  • Slovakia · Folgan Hct

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9d8738a-c710-44e5-a2fb-7bffc86a1e27
GET /v1/drugs/d9d8738a-c710-44e5-a2fb-7bffc86a1e27?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20; 5; 12.5",
  "substance": "OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE",
  "productndc": "49884-786",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1; mg/1",
  "application_number": "ANDA206137",
  "marketing_category": "ANDA"
}

See everything about olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.